title: Adalimumab for treatment of pyoderma gangrenosum.
authors.forename: R G
authors.initials: RG
authors.lastname: Pomerantz
authors.forename: M E
authors.initials: ME
authors.lastname: Husni
authors.forename: E
authors.initials: E
authors.lastname: Mody
authors.forename: A A
authors.initials: AA
authors.lastname: Qureshi
mesh_terms: D000068879:Adalimumab; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006801:Humans; D008875:Middle Aged; D017511:Pyoderma Gangrenosum / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab